CBLI - Cleveland BioLabs, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
3.13
+0.03 (+0.85%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close3.10
Open3.15
Bid3.07 x 300
Ask3.55 x 300
Day's Range3.11 - 3.25
52 Week Range1.22 - 5.55
Volume4,838
Avg. Volume61,096
Market Cap35.31M
Beta-1.03
PE Ratio (TTM)-4.69
EPS (TTM)-0.67
Earnings DateMay 18, 2017 - May 19, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.00
Trade prices are not sourced from all markets
  • Capital Cube13 days ago

    ETFs with exposure to Cleveland BioLabs, Inc. : October 11, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cleveland BioLabs, Inc. Here are 5 ETFs with the largest exposure to CBLI-US. Comparing the performance and risk of Cleveland BioLabs, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cubelast month

    ETFs with exposure to Cleveland BioLabs, Inc. : September 19, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cleveland BioLabs, Inc. Here are 5 ETFs with the largest exposure to CBLI-US. Comparing the performance and risk of Cleveland BioLabs, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Cleveland BioLabs, Inc. :CBLI-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017
    Capital Cubelast month

    Cleveland BioLabs, Inc. :CBLI-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017

    Categories: Yahoo FinanceGet free summary analysis Cleveland BioLabs, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Cleveland BioLabs, Inc. – Onconova Therapeutics Inc., OPKO Health, Inc., Novartis AG Sponsored ADR, Bristol-Myers Squibb Company, Cascadian Therapeutics Inc., Sanofi Sponsored ADR, Amgen Inc., Eli Lilly and ... Read more (Read more...)

  • What You Must Know About Cleveland BioLabs Inc’s (CBLI) Risks
    Simply Wall St.last month

    What You Must Know About Cleveland BioLabs Inc’s (CBLI) Risks

    If you are looking to invest in Cleveland BioLabs Inc’s (NASDAQ:CBLI), or currently own the stock, then you need to understand its beta in order to understand how it canRead More...

  • ACCESSWIRE2 months ago

    Cleveland Biolabs Countermeasure for Acute Radiation Syndrome, Pipeline Review, and Market Potential

    NEW YORK, NY / ACCESSWIRE / August 11, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...

  • Capital Cube3 months ago

    ETFs with exposure to Cleveland BioLabs, Inc. : August 4, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cleveland BioLabs, Inc. Here are 5 ETFs with the largest exposure to CBLI-US. Comparing the performance and risk of Cleveland BioLabs, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube3 months ago

    ETFs with exposure to Cleveland BioLabs, Inc. : July 12, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cleveland BioLabs, Inc. Here are 5 ETFs with the largest exposure to CBLI-US. Comparing the performance and risk of Cleveland BioLabs, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube4 months ago

    ETFs with exposure to Cleveland BioLabs, Inc. : June 26, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cleveland BioLabs, Inc. Here are 5 ETFs with the largest exposure to CBLI-US. Comparing the performance and risk of Cleveland BioLabs, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube4 months ago

    ETFs with exposure to Cleveland BioLabs, Inc. : June 16, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cleveland BioLabs, Inc. Here are 5 ETFs with the largest exposure to CBLI-US. Comparing the performance and risk of Cleveland BioLabs, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Cleveland BioLabs, Inc. :CBLI-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017
    Capital Cube5 months ago

    Cleveland BioLabs, Inc. :CBLI-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017

    Categories: Yahoo FinanceGet free summary analysis Cleveland BioLabs, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Cleveland BioLabs, Inc. – Onconova Therapeutics Inc., OPKO Health, Inc., Novartis AG Sponsored ADR, Bristol-Myers Squibb Company, Cascadian Therapeutics Inc., Amgen Inc., Eli Lilly and Company and GlaxoSmithKline ... Read more (Read more...)

  • Marketwired5 months ago

    Cleveland BioLabs Reports First Quarter 2017 Financial Results and Development Progress

    Cleveland BioLabs, Inc. today reported financial results and development progress for the first quarter ended March 31, 2017.

  • Accesswire6 months ago

    Governments Looking at Cleveland Biolabs Radiation Countermeasure

    NEW YORK, NY / ACCESSWIRE / April 20, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and micro-cap public companies, is issuing a comprehensive ...

  • Capital Cube6 months ago

    ETFs with exposure to Cleveland BioLabs, Inc. : April 19, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cleveland BioLabs, Inc. Here are 5 ETFs with the largest exposure to CBLI-US. Comparing the performance and risk of Cleveland BioLabs, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Accesswire6 months ago

    Today's Research Reports on Biotech Stocks to Watch: Cleveland BioLabs and Infinity Pharmaceuticals

    NEW YORK, NY / ACCESSWIRE / April 18, 2017 / The volatile Biotech Industry has continued to be home to some of the largest gainers on the market in 2017. President Trump's pledge for a faster FDA approval ...

  • Marketwired6 months ago

    Cleveland BioLabs Announces Commencement of In Vivo Biocomparability Study

    Cleveland BioLabs, Inc. today announced that the U.S. Food and Drug Administration has completed its review of a side-by-side analytical comparison of two formulations of entolimod. The FDA agreed with ...

  • Marketwired6 months ago

    Cleveland BioLabs Announces European Medicines Agency Positive Opinion Regarding the Entolimod Pediatric Investigation Plan

    Cleveland BioLabs, Inc. today announced that the European Medicines Agency has accepted the company's pediatric investigation plan , paving the way for submission of a Marketing Authorization Application ...

  • Marketwired6 months ago

    Cleveland BioLabs Announces Webcast of Annual Meeting

    Cleveland BioLabs, Inc. today announced that the Company will webcast its 2017 Annual Meeting of Stockholders on April 21, 2017 at its headquarters in Buffalo, NY.

  • Capital Cube7 months ago

    ETFs with exposure to Cleveland BioLabs, Inc. : April 7, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cleveland BioLabs, Inc. Here are 5 ETFs with the largest exposure to CBLI-US. Comparing the performance and risk of Cleveland BioLabs, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Cleveland BioLabs, Inc. :CBLI-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017
    Capital Cube7 months ago

    Cleveland BioLabs, Inc. :CBLI-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017

    Categories: Yahoo Finance Get free summary analysis Cleveland BioLabs, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Cleveland BioLabs, Inc. – OPKO Health, Inc., Novartis AG Sponsored ADR, Bristol-Myers Squibb Company, Cascadian Therapeutics Inc., Sanofi Sponsored ADR, Amgen Inc., Eli Lilly and Company and GlaxoSmithKline ... Read more (Read more...)

  • Cleveland BioLabs, Inc. :CBLI-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017
    Capital Cube7 months ago

    Cleveland BioLabs, Inc. :CBLI-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017

    Categories: Yahoo Finance Get free summary analysis Cleveland BioLabs, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Cleveland BioLabs, Inc. – OPKO Health, Inc., Novartis AG Sponsored ADR, Bristol-Myers Squibb Company, Cascadian Therapeutics Inc., Sanofi Sponsored ADR, Amgen Inc., Eli Lilly and Company and GlaxoSmithKline ... Read more (Read more...)

  • Marketwired8 months ago

    Cleveland BioLabs Reports 2016 Financial Results and Development Progress

    Cleveland BioLabs, Inc. today reported financial results and development progress for the fourth quarter and year ended December 31, 2016.

  • Capital Cube11 months ago

    ETFs with exposure to Cleveland BioLabs, Inc. : December 7, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Cleveland BioLabs, Inc. Here are 5 ETFs with the largest exposure to CBLI-US. Comparing the performance and risk of Cleveland BioLabs, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Marketwired11 months ago

    Cleveland BioLabs Reports Third Quarter 2016 Financial Results and Development Progress

    Cleveland BioLabs, Inc. today reported financial results and development progress for the third quarter ended September 30, 2016.